Brief: Taysha Gene Therapies Q2 Loss Per Share Of $1.09
16/08/2021 12:38
Aug 16 (Reuters) - Taysha Gene Therapies Inc TSHA.O :
* TAYSHA GENE THERAPIES REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q2 LOSS PER SHARE $1.09
* RAISIO OYJ - AS OF JUNE 30, 2021, TAYSHA HAD $197.4
MILLION IN
CASH AND CASH EQUIVALENTS
Source text for Eikon: ID:nBwb7fvJ3a
Further company coverage: TSHA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taysha Gene Therapies
See all newsUniqure jumps after FDA vaccines chief Vinay Prasad to step down
US FDA names agency critic Vinay Prasad as top vaccine official (updated)
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
US FDA names oncologist Vinay Prasad as top vaccine official (updated)